bsmith3	10.4161/cbt.6.2.3588	<http://dx.doi.org/10.4161/cbt.6.2.3588>; rel="canonical", <http://www.tandfonline.com/doi/pdf/10.4161/cbt.6.2.3588>; version="vor"; rel="item"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.4161/cbt.6.2.3588"><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/nicole-c-mcknight-1wtucinh69p7o"><j.3:name>Nicole C. McKnight</j.3:name><j.3:familyName>McKnight</j.3:familyName><j.3:givenName>Nicole C.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/ben-g-neel-1wtucinh69p7o"><j.3:name>Ben G. Neel</j.3:name><j.3:familyName>Neel</j.3:familyName><j.3:givenName>Ben G.</j.3:givenName></j.3:Person></j.0:creator><j.1:endingPage>201</j.1:endingPage><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#gYearMonth" >2007-02</j.0:date><owl:sameAs rdf:resource="info:doi/10.4161/cbt.6.2.3588"/><j.1:startingPage>195</j.1:startingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/stevan-p-balk-1wtucinh69p7o"><j.3:name>Stevan P. Balk</j.3:name><j.3:familyName>Balk</j.3:familyName><j.3:givenName>Stevan P.</j.3:givenName></j.3:Person></j.0:creator><j.0:identifier>10.4161/cbt.6.2.3588</j.0:identifier><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/m-golam-mohi-1wtucinh69p7o"><j.3:name>M. Golam Mohi</j.3:name><j.3:familyName>Mohi</j.3:familyName><j.3:givenName>M. Golam</j.3:givenName></j.3:Person></j.0:creator><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/1538-4047"><owl:sameAs>urn:issn:1538-4047</owl:sameAs><j.1:issn>1555-8576</j.1:issn><j.2:issn>1555-8576</j.2:issn><owl:sameAs>urn:issn:1555-8576</owl:sameAs><j.0:title>Cancer Biology &amp; Therapy</j.0:title><j.1:issn>1538-4047</j.1:issn><j.2:issn>1538-4047</j.2:issn></j.2:Journal></j.0:isPartOf><j.2:pageStart>195</j.2:pageStart><j.0:publisher>Informa UK Limited</j.0:publisher><j.1:volume>6</j.1:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/bradley-smith-1wtucinh69p7o"><j.3:name>Bradley Smith</j.3:name><j.3:familyName>Smith</j.3:familyName><j.3:givenName>Bradley</j.3:givenName></j.3:Person></j.0:creator><j.2:doi>10.4161/cbt.6.2.3588</j.2:doi><j.1:doi>10.4161/cbt.6.2.3588</j.1:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/glenn-j-bubley-1wtucinh69p7o"><j.3:name>Glenn J. Bubley</j.3:name><j.3:familyName>Bubley</j.3:familyName><j.3:givenName>Glenn J.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/david-masiello-1wtucinh69p7o"><j.3:name>David Masiello</j.3:name><j.3:familyName>Masiello</j.3:familyName><j.3:givenName>David</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="doi:10.4161/cbt.6.2.3588"/><j.0:title>Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer</j.0:title><j.2:pageEnd>201</j.2:pageEnd><j.2:volume>6</j.2:volume></rdf:Description></rdf:RDF>
